Medical News

RSS

Mo. Gov. faces defining choice on abortion bills; La. House approves abortion ban after 20 weeks

Missouri's governor faces tough choices on a pair of abortion bills awaiting his signature or veto -- moves that could have national implications. In the meantime, Louisiana lawmakers have approved a bill banning abortions after 20 weeks of pregnancy.

5 Jun 2012

HDL to offer testing services based on Critical Diagnostics' Presage ST2 Assay

Critical Diagnostics, a U.S.-based biomarker company focused on cardiovascular diseases and Health Diagnostic Laboratory, Inc. (HDL, Inc.), announced today an agreement under which HDL, Inc. will soon offer ST2 testing services based on Critical Diagnostics' Presage ST2 Assay.

5 Jun 2012

Ways to improve care and reduce the high cost for Medicare beneficiaries highlighted by Hopkins study

It’s well known that a relatively small percentage of chronically ill patients account for a disproportionate amount of health care dollars. Now, a multicenter study led by Johns Hopkins researcher Bruce Leff, M.D., might provide insights into how to cut Medicare costs while improving health care for older adults suffering from chronic health conditions.

5 Jun 2012

Joint UNAIDS/UNDP briefing highlights potential impacts of free trade agreements on public health

"A new UNAIDS/UNDP joint issues brief highlights the potential impacts of free trade agreements on public health," UNAIDS reports in a feature story on its website. "The brief concludes that 'to retain the benefits of [flexibilities in the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS)], countries at a minimum should avoid entering into free trade agreements that contain obligations that can impact on pharmaceutical price or availability,'" the article states.

5 Jun 2012

Risk of recurrent shingles episode is relatively low: Study

People who have had an episode of herpes zoster, also known as shingles, face a relatively low short-term risk of developing shingles, according to a Kaiser Permanente Southern California study published online in the Journal of Infectious Diseases. These findings suggest that among people with immune systems that have not been compromised, the risk of a second shingles episode is low.

5 Jun 2012

U.S., Norway announce new private-public initiative to improve maternal health in developing countries

Speaking at a health conference in Norway on Friday, U.S. Secretary of State Hillary Clinton announced the United States would provide $75 million a new private-public effort, dubbed "Saving Mothers, Giving Life," which aims "to improve the health of mothers and their babies in developing countries," Agence France-Presse reports.

5 Jun 2012

Cannabinoid therapy helps provide effective analgesia for cancer patients with pain

An investigational cannabinoid therapy helped provide effective analgesia when used as an adjuvant medication for cancer patients with pain that responded poorly to opioids, according to results of a multicenter trial reported in The Journal of Pain, published by the American Pain Society.

5 Jun 2012

Zimbabwe's successful PMTCT efforts serve as a 'model' for other countries in drive to eliminate pediatric AIDS

"Zimbabwe is one of the key countries to watch in the drive to eliminate pediatric AIDS in Africa," Chip Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation, writes in this post in the Huffington Post's "Global Motherhood" blog.

5 Jun 2012

New data from CardioFocus’ HeartLight EAS clinical study on AF

CardioFocus, Inc., developer of the HeartLight Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announces new worldwide data with its technology was presented during the scientific sessions at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions, in Boston, MA last month.

5 Jun 2012

Scientists discover neural mechanism for conscious perception

When people close their eyes, they can form mental images of things that exist only in their minds. Neuroscientists studying this phenomenon at medical schools in the Texas Medical Center believe that there may be a way to use these mental images to help some of the estimated 39 million people worldwide who are blind.

5 Jun 2012

Jennerex announces data from JX-594 clinical studies on cancer

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that data relating to the company's oncolytic virus therapy for cancer was featured in three separate abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting currently taking place in Chicago, Illinois.

5 Jun 2012

Sapio announces availability of Exemplar Biomarker Discovery LIMS

Sapio Sciences is pleased to announce the immediate availability of Exemplar Biomarker Discovery LIMS.

5 Jun 2012

Esperance presents results from EP-100 Phase 1 study on solid tumors at ASCO annual meeting

Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane‐disrupting peptide (tMDP) in advanced solid tumors at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.

5 Jun 2012

Researchers identify predictive biomarker for Parkinson's disease

Because there is currently no laboratory test that can diagnose Parkinson's disease, it is practically impossible to detect those individuals who are in the earliest stages of the disease. As a result, Parkinson's disease can only be diagnosed by a clinical neurological examination based on findings suggestive of the disease.

5 Jun 2012

Results from Celgene’s ABRAXANE plus gemcitabine clinical study on resectable pancreatic cancer

Celgene International Sàrl, a subsidiary of Celgene Corporation today announced results from a study of ABRAXANE(paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in combination with gemcitabine in patients with resectable pancreatic cancer.

5 Jun 2012

HCMS, ACOEM announce important expansion to Blueprint for Health

The American College of Occupational and Environmental Medicine (ACOEM) and the HCMS Group have announced an important expansion to their "Blueprint for Health" - a free internet-based calculating tool that helps employers better comprehend and analyze the impact of medical costs, absence, and work impairment among their employees.

5 Jun 2012

Ipsen, Active Biotech present OS data from tasquinimod Phase II study on CRPC at ASCO 2012

Active Biotech and Ipsen today presented overall survival (OS) data from the tasquinimod Phase II study in chemotherapy-naïve metastatic castrate resistant prostate cancer (CRPC) at the scientific conference "2012 ASCO Annual Meeting" held in Chicago (USA).

5 Jun 2012

Medical News

Mo. Gov. faces defining choice on abortion bills; La. House approves abortion ban after 20 weeks

HDL to offer testing services based on Critical Diagnostics' Presage ST2 Assay

Ways to improve care and reduce the high cost for Medicare beneficiaries highlighted by Hopkins study

Joint UNAIDS/UNDP briefing highlights potential impacts of free trade agreements on public health

Risk of recurrent shingles episode is relatively low: Study

U.S., Norway announce new private-public initiative to improve maternal health in developing countries

Cannabinoid therapy helps provide effective analgesia for cancer patients with pain

Zimbabwe's successful PMTCT efforts serve as a 'model' for other countries in drive to eliminate pediatric AIDS

New data from CardioFocus’ HeartLight EAS clinical study on AF

Scientists discover neural mechanism for conscious perception

Jennerex announces data from JX-594 clinical studies on cancer

Sapio announces availability of Exemplar Biomarker Discovery LIMS

Esperance presents results from EP-100 Phase 1 study on solid tumors at ASCO annual meeting

Researchers identify predictive biomarker for Parkinson's disease

Results from Celgene’s ABRAXANE plus gemcitabine clinical study on resectable pancreatic cancer

HCMS, ACOEM announce important expansion to Blueprint for Health

Ipsen, Active Biotech present OS data from tasquinimod Phase II study on CRPC at ASCO 2012

A.M. Best upgrades FSR and ICR for ODSHP

Alnylam announces results from ALN-VSP Phase I study on liver cancers

BIOREM closes private placement

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Building quality into drug development for safer, faster medicines

Latest News